Astria Therapeutics
ATXS
ATXS
28 hedge funds and large institutions have $31.3M invested in Astria Therapeutics in 2019 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
8% more funds holding
Funds holding: 26 → 28 (+2)
1.13% more ownership
Funds ownership: 6.34% → 7.48% (+1.1%)
Holders
28
Holding in Top 10
2
Calls
$6.65M
Puts
–
Top Buyers
| 1 | +$742K | |
| 2 | +$498K | |
| 3 | +$328K | |
| 4 |
BlackRock
New York
|
+$319K |
| 5 |
JPMorgan Chase & Co
New York
|
+$120K |
Top Sellers
| 1 | -$394K | |
| 2 | -$330K | |
| 3 | -$113K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$89K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$67.8K |